Publications

5674 Results

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an Intergroup trial of the Eastern Cooperative Oncology Group

Authors
MK Gibson;Y Li;B Murphy;MHA Hussain;RC DeConti;J Ensley;AA Forastiere
Journal / Conference
Journal of Clinical Oncology 23(15):3562-3567
Year
2005
Research Committee(s)
Head and Neck
Study Number(s)
E1395

Gene expression profiling of bulk CD138+ plasma cells in preneoplastic gammopathy/asymptomatic myeloma identifies distinct subsets of patients

Authors
MV Dhodapkar;F Zhan;E Rasmussen;B Burington;B Durie;J Crowley;B Barlogie;J Shaughnessy
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #1218
Year
2005
Research Committee(s)
Myeloma
Study Number(s)
S0120

A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group (E2100)

Authors
KD Miller;M Wang;JR Gralow;M Dickler;MA Cobleigh;EA Perez;TN Shenkier;NE Davidson
Journal / Conference
Breast Cancer Research and Treatment 94(Suppl 1):S6(#3)
Year
2005
Research Committee(s)
Breast
Study Number(s)
CTSU/E2100

Exploratory analysis from NCCTG N9831: do clinical and laboratory characteristics predict cardiac toxicity of trastuzumab when administered as a component of adjuvant therapy?

Authors
EA Perez;VJ Suman;NE Davidson;PA Kaufman;S Martino;SR Dakhil;JN Ingle;RJ Rodeheffer;BJ Gersh;AS Jaffe
Journal / Conference
Breast Cancer Research and Treatment 94(Suppl 1):S96(#2038)
Year
2005
Research Committee(s)
Breast
Study Number(s)
N9831

HIGH expression of the microtubule-associated protein, tau, strongly predicts improved progression free and overall survival in patients with metastatic HER-2 negative breast cancers treated with docetaxel and vinorelbine plus filgrastim

Authors
AM Gown;DO Treaba;LC Goldstein;PL Porter;JR Gralow;RB Livingston;S Tam;IT Yeh;DF Hayes;W Barlow;D Lew
Journal / Conference
Breast Cancer Research and Treatment 94(Suppl 1):S50(#1035)
Year
2005
Research Committee(s)
Breast
Study Number(s)
S0102

Five year follow-up of INT C9741: dose-dense (DD) chemotherapy (CRx) is safe and effective.

Authors
C Hudis;M Citron;D Berry;C Cirrincione;W Gradishar;N Davidson;S Martino;R Livingston;J Ingle;E Perez;J Abrams;R Schilsky;M Ellis;H Muss;L Norton;E Winer
Journal / Conference
Breast Cancer Research and Treatment 94(Suppl 1):S20-S21(#41)
Year
2005
Research Committee(s)
Breast
Study Number(s)
C9741

A phase II trial of BAY 43-9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). a Southwest Oncology Group (SWOG) trial

Authors
S Williamson;J Moon;C Huang;G Wolf;S Urba
Journal / Conference
European Journal of Cancer Supplements 3(2):286 (#995)
Year
2005
Research Committee(s)
Head and Neck
Study Number(s)
S0420

Ixabepilone (epothilone b analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111

Authors
M Hussain;CM Tangen;PN Lara;UN Vaishampayan;DP Petrylak;AD Colevas;WA Sakr;ED Crawford
Journal / Conference
Journal of Clinical Oncology 23(34):8724-8729
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
S0111

Meta-analysis to evaluate the role of interferon in follicular lymphoma.

Authors
AZS Rohatiner;WM Gregory;B Peterson;E Borden;P Solal-Celigny;A Hagenbeek;RI Fisher;M Unterhalt;R Arranz;T Chisesi;A Aviles;TA Lister
Journal / Conference
Journal of Clinical Oncology 23(10):2215-2223
Year
2005
Research Committee(s)
Lymphoma

Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited.

Authors
EA Klein;CM Tangen;PJ Goodman;SM Lippman;IM Thompson
Journal / Conference
Journal of Clinical Oncology 23(30):7460-7466
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217